Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials
Pipette.com announces 3 Sartorius Biohit promotions for labs seeking to maximize purchasing capacity with 2 weeks left out of the year. - December 21, 2014 - Pipette.com
Creative Biomart Newly Introduced Multiplex Protein Detect Assay
Creative Biomart, a world leading biotech company and the commitment of which is to improving people’s life by assisting scientists with their research, has announced today for its official release of Multiplex Protein Detect Assay Service. This release was said to provide better protein... - December 21, 2014 - Creative Biomart
Pennsylvania Biotechnology Center Hires New Chief Operating Officer
A 20-year veteran of behavioral health and social service sectors, Lou Kassa will direct daily operations at the Biotech Center, the Hepatitis B Foundation, and the Baruch S. Blumberg Institute. - December 18, 2014 - Hepatitis B Foundation
Theravectys Launches Its New Website & Wins Deloitte’s Technology Fast50 "2014 Biotech d’Avenir" Award
A rewarding November for the promising French biotech: a prestigious prize & an impactful communication tool! Theravectys wins Deloitte Technology Fast 50 “2014 Biotech d’Avenir,” a prize awarded to one of the fastest-growing, most innovative & dynamic biotech company of the year. In addition, Theravectys is proud to announce the launch of its responsive and easy-to-navigate website www.theravectys.com featuring new sections & content. - December 18, 2014 - Theravectys
Advanced Cancer Therapeutics’ PFK-158 Featured in CEO/CFO Magazine; Announces MD Anderson and UT Health Science Center San Antonio Added as Clinical Trial Sites
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, has been featured in the December 15, 2014 issue of CEO/CFO Magazine in which ACT President and CEO Randall B. Riggs discusses PFK-158, a first-in-man/first-in-class inhibitor of PFKFB3, an enzyme that controls glycolysis and that is overexpressed in most hematological and solid tumors. - December 17, 2014 - Advanced Cancer Therapeutics
Global Cell and Tissue Culture Supplies Market Will Reach $28,108.3 Million in 2020 by Persistence Market Research
Some of the major companies dealing in the global market for cell and tissue culture supplies market are Thermo Fisher Scientific, Inc., BD Diagnostics, EMD Millipore, Corning, Inc., Lonza Group, and others. - December 17, 2014 - Persistence Market Research
Careers in Biotech/Pharmaceutical Industry - Professional and Personal Perspectives by SAPA-WCBC
Seasoned pharmaceutical professionals from a diverse background including drug discovery, preclinical/clinical development, regulatory & medical affairs, diagnostics and personalized medicine, management consulting, etc., will share their experience and perspectives in their respective career paths. - December 12, 2014 - Sino-American Pharmaceutical Professionals Association
Paras Biopharmaceuticals Wins International Award
Paras Biopharmaceuticals wins the 2014 European Biopharmaceuticals Technology Innovation Leadership Award by Frost & Sullivan. - December 11, 2014 - Paras Biopharmaceuticals Finland Oy
AveXis Announces Dosing of First Patient in Intermediate Cohort in Gene Transfer Trial
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced that the first patient in the intermediate cohort in the Gene Transfer Clinical Trial for SMA Type 1 has... - December 10, 2014 - AveXis Inc.
Opus Bio to License CD22 CAR T Cell Technology to Juno
Opus Bio, Inc., today announced that Juno Therapeutics, Inc. has entered into an agreement to obtain a license for the company’s CAR-T cell product candidate targeting CD22, a protein expressed on most B cell leukemias and lymphomas. The CD22-targeted CAR T cell product candidate was... - December 05, 2014 - Biomark Capital
AveXis Announces Launch of New Patient-Oriented Website Focused on Spinal Muscular Atrophy
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), is pleased to announce the launch of the company’s brand new website specifically focused on SMA: www.smastudy.org. - December 04, 2014 - AveXis Inc.
Creative Bioarray Announces Product Promotiom for Magic™ Serum-Free Freezing Medium
Creative Bioarray announces its product promotion for Magic™ serum-free freezing medium towards the worldwide market. - November 26, 2014 - Creative Bioarray
NanoCellect’s WOLF Cell Sorter Attracts Additional $2.8M from NIH
NanoCellect Biomedical announced new NIH funding and technical advances on their WOLF Cell Sorter. NanoCellect has the goal of making the “coin star” for cell biologists. “Instead of pennies and nickels, we are counting and sorting specific cells,” says José Morachis,... - November 26, 2014 - NanoSort
Creative Biomart’s Most-Favored Services List is Available Now
Creative Biomart, a world leading biotech company that offers recombinant proteins, antibodies, antigens and a wide range of biotech services worldwide, today has released its most favored services list officially. It was said that this was done to make them have a better understanding of what... - November 22, 2014 - Creative Biomart
Logos Biosystems to License “Clarity™” Technology from Stanford University
A novel tissue clearing technology allows researchers to obtain optically transparent and macromolecular permeable brain tissue. - November 21, 2014 - Logos Biosystems, Inc
AveXis to Present at the 26th Annual Piper Jaffray Healthcare Conference
AveXis, a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy, today announced that Mr. John Carbona, Chief Executive Officer, and Dr. Brian Kaspar will present at the 26th Annual Piper Jaffray... - November 21, 2014 - AveXis Inc.
Creative Diagnostics Announces Product Promotion for Antigens Towards the Worldwide Market
Creative Diagnostics - Quality monoclonal and polyclonal antibody provider for the global market at very substantial savings begins at this thanksgiving month. - November 19, 2014 - Creative Diagnostics
Creative Bioarray’s High Quality Dry Bath Incubators
Creative Bioarray is a well-recognized biotech company. The company is specializing in providing bio-laboratory products and services such as human tissue, animal tissue, tissue array, microorganisms, cells, probes, cell services, biosample services, histology services, and also laboratory equipments. - November 16, 2014 - Creative Bioarray
Eminent Spine Releases Updated King Cobra® and Copperhead® White Paper
Eminent Spine has released an updated white paper by Dr. Stephen Courtney. The study validates the extensive research and development by Eminent Spine providing safe and effective spinal products. The study of 180 patients and 196 plates and 1,320 cervical screws and 679 PEEK cervical cages,... - November 12, 2014 - Eminent Spine
Eminent Spine Black Diamondback Rattlesnake™ Successfully Implanted
Eminent Spine is proud to announce that spinal surgeon Dr. Stephen Courtney in Plano, TX performed the company’s first lateral lumbar plate surgery - the “Black Diamond Rattlesnake™.” The surgery was performed on October 27, 2014. Dr. Courtney has successfully implanted the... - November 12, 2014 - Eminent Spine
Affinity Biologicals Inc. to Showcase their Factor Deficient Plasmas for Hemostasis & Thrombosis Research at the MEDICA 2014 in Düsseldorf, Germany
On November 12, 2014 through to November 15, 2015, Affinity Biologicals Inc. will be attending the annual MEDICA trade fair in Düsseldorf, Germany to showcase their line of factor deficient/ factor depleted plasmas. - November 11, 2014 - Affinity Biologicals
Affinity Biologicals Inc. Launches Their Debut VisuLize™ Factor VII Antigen – A Polyclonal Antibody Based ELISA Kit
As a licensed medical device manufacturer that is recognized by the US Food and Drug Administration, Health Canada, and European regulatory authorities, Affinity Biologicals Inc. is constantly striving to produce reliable reagents for various applications in the health science industry. - November 11, 2014 - Affinity Biologicals
Creative Bioarray’s WISP-PTC Dry Bath Incubator
Creative Bioarray launches another brand new dry bath incubator: WISP-PTC Dry Bath Incubator, with the support of its advanced technology platform. - November 08, 2014 - Creative Bioarray
Educational Conference Specifically for Pharmaceutical Packaging Engineers to be Held Early 2015
Interactive Sessions to Address Prevention of Counterfeit Products, FDA Expectations, Future of Sustainability Trends - November 07, 2014 - Q1 Productions
Creative Bioarray’s 3-in-I Mini Dry Bath Incubator
Creative Bioarray launches its 3-in-1 multifunctional Mini Dry Bath Incubator - WISP-TR Dry Bath Incubator. - November 06, 2014 - Creative Bioarray
Enzyme Activity Assay Service Are Available in Creative Biomart
Creative Biomart, a world leading supplier of recombinant proteins, antibodies, enzymes and other biotech services for the research community in the field of biology, has announced today for its official release of the novel service-- Enzyme activity assay. This assay is in the aim of assisting... - November 06, 2014 - Creative Biomart
VoiceOver® Solution is the VA’s Choice for Speech Enabled Pathology Reporting
Voicebrook addresses pathologist needs in a unique and complex reporting environment. - November 05, 2014 - Voicebrook, Inc.
ABR Launches New Mycoplasma Testing Services
ABR (now a VMRD division) announced today the availability of new testing services that can detect the presence of mycoplasma in animal origin products, master virus seeds, and other sample types. The new services satisfy various regulatory standards including US Pharmacopoeia (USP), European... - November 04, 2014 - VMRD, Inc.
Liftstream Report Finds Ten Men for Every Woman Present in Biotech Boardrooms
Liftstream Ltd, a company providing executive recruitment services to the biotechnology sector, announces the publication of its new gender diversity report, “Diversifying the Outlook – The X&Y of Biotechnology Leadership,” a detailed analysis of women leaders in European and US life biotech companies. The research covers 700 companies, 60 C-level interviews and 530 survey respondents. - October 25, 2014 - Liftstream
IQ4I Research & Consultancy Published a New Report on PCR Technologies (qPCR, dPCR) Global Market and Estimated It to be Worth $13.4 Billion by 2020
The global PCR technologies global market is expected to reach $13.4 billion by 2020 and is mainly driven by factors such as the booming healthcare technology market with demand for innovative technology for early and accurate diagnosis of life threatening diseases, rising investments in companion diagnostics, advent of digital PCR, expiry of key players PCR patents, increasing demand for PCR in genetic and molecular testing. - October 22, 2014 - IQ4I Research & Consultancy Pvt. Ltd.
North Carolina Leaders to Launch New Economic Development Platform Promoting State's Global Leadership in Ag Biotech
North Carolina's Secretary of Commerce Sharon Allred Decker and Commissioner of Agriculture Steve Troxler to unveil state's new name for ag biotechnology at press conference and launch event, Wednesday, November 5. - October 17, 2014 - North Carolina Biotechnology Center
Creative Diagnostics Releases the Hot Products of October for Monoclonal Antibodies
Creative Diagnostics announced the release of its hot products of Oct. 2014 for monoclonal antibodies. - October 17, 2014 - Creative Diagnostics
OutsourcePharma Advisory Board CRO Reviews Database Surpasses Growth Milestone
Online community of outsourcing decision makers doubles its CRO reviews database - October 15, 2014 - Life Science Strategy Group, LLC
Creative Biomart Newly Introduced It’s Fc Fusion Protein Production Service
Creative Biomart, a word leading Biotech Company had newly released its novel service of Fc Fusion Protein Production Service in the aim of providing more choices for the scientists conducting biomedical and immunology research. The potential clinical application of cytokins to modulate immune... - October 10, 2014 - Creative Biomart
AveXis Announces the Completion of Dosing of the Low Dose Cohort in US Clinical Trial for Spinal Muscular Atrophy
AveXis, Inc., a clinic-stage gene therapy company, today announced the completion of dosing in the low dose cohort in the world's first human gene therapy trial for the treatment of infants with spinal muscular atrophy (SMA). The trial (NCT02122952) opened for enrollment in April... - October 08, 2014 - AveXis Inc.
Stem Cells Used to Successfully Treat Chronic Achilles Tendon Injury
Biologic Therapies, Inc. (BTI), a company that specializes in the design and development of medical devices and procedures for the regenerative medicine market, announced today that its products have been used to successfully treat a chronically injured Achilles tendon with stem cell therapy. A... - October 06, 2014 - Biologic Therapies
Ability of Semiconductor DNA Sequencing to Transform Healthcare and Save Lives Recognised by the 2014 Faraday Medal to Professor Chris Toumazou
DNA Electronics (‘DNAe’), the inventors of semiconductor DNA sequencing technology and developers of a new, revolutionary point-of-need test for sepsis, announces today that its founder, Chairman and CEO Professor Chris Toumazou FRS, FREng, FMEDSci, FIET, FIEEE, FCGI, FRSM has been... - October 04, 2014 - DNA Electronics
AveXis Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for chariSMA for the Treatment of Spinal Muscular Atrophy
AveXis Inc., a synthetic biology platform company primarily focused on developing treatments for Spinal Muscular Atrophy (SMA) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its product scAAV9, called chariSMA to treat Spinal Muscular Atrophy... - October 04, 2014 - AveXis Inc.
The Knowledge Congress Has Scheduled a Live Webcast on Hot Topics in the Pharma Biotech Industries Live Webcast
This course offers an overview of the latest trends and best practices with respect to hot issues surrounding the Pharmaceutical and Biotech industries. A panel of thought leaders and practitioners will help firms better understand how to apply this law or business trend to their company and/or clients. Key topics include: Pharma Biotech industries 2014: An overview, Latest trends in Pharma Biotech industries, Hot topics and regulatory issues, Best practices, etc. - October 02, 2014 - The Knowledge Group
John J. Molenda, PhD, Partner, Steptoe & Johnson LLP to Speak at KG’s Hot Topics in the Pharma Biotech Industries Live Webcast
This course offers an overview of the latest trends and best practices with respect to hot issues surrounding the Pharmaceutical and Biotech industries. A panel of thought leaders and practitioners will help firms better understand how to apply this law or business trend to their company and/or clients. Key topics include: Pharma Biotech industries 2014: An overview, Latest trends in Pharma Biotech industries, Hot topics and regulatory issues, Best practices, Up-to-minute regulatory updates, etc - October 02, 2014 - The Knowledge Group
National Algae Association Claims That Algae Won't Be Grown in Washington, DC
After over 6 decades of time, and billions of dollars spent at the direction of the Department of Energy and other government agencies, one thing is for sure – algae for fuels will never be grown in Washington, D.C. "The algae production industry does not need lobbyists who have no... - October 01, 2014 - national algae asssociation
Voicebrook Announces Participation at 2014 Southeast Chairs and Administrators Conference
Company to demonstrate how its solutions address pathologist needs in a complex academic reporting environment. - September 26, 2014 - Voicebrook, Inc.
DNAe Completes Its Leadership Team with Key Operational and R&D Appointments as It Takes Forward Its DNA Diagnostic Test for Sepsis
DNA Electronics ("DNAe"), the inventors of semiconductor DNA sequencing technology and developers of a new, revolutionary point-of-need test for sepsis, today announced the completion of its leadership team with the appointment of Kevin Stearn as Operational Director, and Dr David Edington as Vice President, R&D. - September 24, 2014 - DNA Electronics
Clinical Network Services (CNS) and Ventac Partners Sign Cooperative Partnership
Clinical Network Services (CNS) an integrated service consultancy focused on product development and Ventac Partners, a life science consulting firm, today announced that they have signed a cooperative partnership agreement to provide joint service offerings in the biotech and pharma sectors in fundraising, company evolution and drug development. The partnership pools the corporate expertise of Ventac Partners with the regulatory expertise of CNS and expands the geographical reach of both. - September 22, 2014 - Ventac Partners
Creative Biomart Morning Talk for Mutagenesis Services
Creative BioMart, a world leading Biotech Company, has conducted a morning talk to discuss its mutagenesis. This talk lasted for nearly one hour. Mutagenesis is a fundamentally important DNA manipulation technique. It involves changing the base sequence of the DNA molecule, usually for the... - September 18, 2014 - Creative Biomart
Dr Frank Tomecek Receives Risk All Star Award
Emerge Diagnostics, is pleased to announce today that Frank Tomecek, MD, received the Risk All Star Award from Risk & Insurance for his groundbreaking work with Emerge Diagnostics. Risk All Stars stand out from their peers by overcoming challenges through creativity, passion, and perseverance. - September 15, 2014 - Emerge Diagnostics
Pathology Diagnostics Ltd (PDL) Wins Prestigious Biomedical Catalyst (BMC) Scheme Award
Pathology Diagnostics Ltd is one of the earliest SME recipients of the £180 million Technology Strategy Board (the UK’s Innovation Agency) Biomedical Catalyst funding programme; winning a Biomedical Catalyst feasibility award in the second round of the BMC scheme in December 2012. The... - September 12, 2014 - Pathology Diagnostics Ltd
FDA Approves PleximmuneTM for Personalized Prediction of Transplant Rejection in Children
Today the FDA announced approval of PleximmuneTM, a blood test from the Pittsburgh-based biotech company Plexision. This test predicts acute cellular rejection of transplanted livers and intestines in children. PleximmuneTM is a first-in-class test to determine a personalized rejection-risk index... - September 11, 2014 - Plexision
VIRUN® NutraBIOsciences™ Granted Patent 261124 in India, Redesigns Website, Omega-3 Summit at Supply Side West and CEO is Again Scheduled to Speak at Cal Poly Pomona
VIRUN has been granted patent number 261124 titled, Compositions Comprising a Mucoadhesive Protein and an Active Principle for Mucosal Delivery of Said Agents. Also, VIRUN has re-designed their website to include brands, a product description page, video as well as a news and PR page. Included in the newly renovated website is an events page; with the growing interest in VIRUN, such as scheduled forums, lectures, expos and webinars, it was imperative this new website share these experiences. - September 11, 2014 - VIRUN
Creative Biomart Newly Introduced Its Stable Cell Line Service
Creative Biomart today has given an announcement that they would release their new service-stable cell line service in this very day to meet their customer’s need. Stable cell lines are essential for protein and antibody and cell-based assays. But the processes required for the generation of... - September 11, 2014 - Creative Biomart